MAPK3 and diabetic retinopathy: In this research, treatment with an Asian plant extract called astragaloside IV was performed, observing a decrease in ERK1/2 activation, and therefore reducing RGC dysfunction on db/db mice with diabetic retinopathy [92]; Figure 2.